Literature DB >> 18823370

Dopaminergic system dysregulation in the mrsk2_KO mouse, an animal model of the Coffin-Lowry syndrome.

Patricia Marques Pereira1, Michael Gruss, Katharina Braun, Nicolas Foos, Solange Pannetier, André Hanauer.   

Abstract

The Coffin-Lowry syndrome, a rare syndromic form of X-linked mental retardation, is caused by loss-of-function mutations in the hRSK2 (RPS6KA3) gene. To further investigate RSK2 (90-kDa ribosomal S6 kinase) implication in cognitive processes, a mrsk2_KO mouse has previously been generated as an animal model of Coffin-Lowry syndrome. The aim of the present study was to identify possible neurochemical dysregulation associated with the behavioral and morphological abnormalities exhibited by mrsk2_KO mice. A cortical dopamine level increase was found in mrsk2_KO mice that was accompanied by an over-expression of dopamine receptor of type 2 and the dopamine transporter. We also detected an increase of total and phosphorylated extracellular regulated kinase that may be responsible for the increased level of tyrosine hydroxylase phosphorylation also observed. By taking into consideration previously reported data, our results strongly suggest that the dopaminergic dysregulation in mrsk2_KO mice may be caused, at least in part, by tyrosine hydroxylase hyperactivity. This cortical hyperdopaminergia may explain some non-cognitive but also cognitive alterations exhibited by mrsk2_KO mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823370     DOI: 10.1111/j.1471-4159.2008.05703.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  RSK2 signaling in medial habenula contributes to acute morphine analgesia.

Authors:  Emmanuel Darcq; Katia Befort; Pascale Koebel; Solange Pannetier; Megan K Mahoney; Claire Gaveriaux-Ruff; André Hanauer; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

2.  Transcriptome profile reveals AMPA receptor dysfunction in the hippocampus of the Rsk2-knockout mice, an animal model of Coffin-Lowry syndrome.

Authors:  Tahir Mehmood; Anne Schneider; Jérémie Sibille; Jérémie Sibillec; Patricia Marques Pereira; Solange Pannetier; Mohamed Raafet Ammar; Doulaye Dembele; Christelle Thibault-Carpentier; Nathalie Rouach; André Hanauer
Journal:  Hum Genet       Date:  2010-11-30       Impact factor: 4.132

Review 3.  Coffin-Lowry syndrome.

Authors:  Patricia Marques Pereira; Anne Schneider; Solange Pannetier; Delphine Heron; André Hanauer
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

4.  Loss of the Coffin-Lowry syndrome-associated gene RSK2 alters ERK activity, synaptic function and axonal transport in Drosophila motoneurons.

Authors:  Katherina Beck; Nadine Ehmann; Till F M Andlauer; Dmitrij Ljaschenko; Katrin Strecker; Matthias Fischer; Robert J Kittel; Thomas Raabe
Journal:  Dis Model Mech       Date:  2015-09-03       Impact factor: 5.758

Review 5.  Animal Models for Coffin-Lowry Syndrome: RSK2 and Nervous System Dysfunction.

Authors:  Matthias Fischer; Thomas Raabe
Journal:  Front Behav Neurosci       Date:  2018-05-23       Impact factor: 3.558

6.  Drosophila RSK Influences the Pace of the Circadian Clock by Negative Regulation of Protein Kinase Shaggy Activity.

Authors:  Katherina Beck; Anna Hovhanyan; Pamela Menegazzi; Charlotte Helfrich-Förster; Thomas Raabe
Journal:  Front Mol Neurosci       Date:  2018-04-13       Impact factor: 5.639

7.  Rsk2 Knockdown in PC12 Cells Results in Sp1 Dependent Increased Expression of the Gria2 Gene, Encoding the AMPA Receptor Subunit GluR2.

Authors:  Tahir Mehmood; Anne Schneider; Solange Pannetier; André Hanauer
Journal:  Int J Mol Sci       Date:  2013-02-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.